[go: up one dir, main page]

DK0750492T3 - Inhalationspræparat med indhold af lactose-pellets - Google Patents

Inhalationspræparat med indhold af lactose-pellets

Info

Publication number
DK0750492T3
DK0750492T3 DK95913091T DK95913091T DK0750492T3 DK 0750492 T3 DK0750492 T3 DK 0750492T3 DK 95913091 T DK95913091 T DK 95913091T DK 95913091 T DK95913091 T DK 95913091T DK 0750492 T3 DK0750492 T3 DK 0750492T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
preparation containing
inhalation
containing lactose
inhalation preparation
Prior art date
Application number
DK95913091T
Other languages
English (en)
Inventor
Gerald Wynn Hallworth
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10751813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0750492(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0750492T3 publication Critical patent/DK0750492T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95913091T 1994-03-15 1995-03-13 Inhalationspræparat med indhold af lactose-pellets DK0750492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9404945A GB9404945D0 (en) 1994-03-15 1994-03-15 Pharmaceutical composition
PCT/EP1995/000917 WO1995024889A1 (en) 1994-03-15 1995-03-13 Inhalation composition containing lactose pellets

Publications (1)

Publication Number Publication Date
DK0750492T3 true DK0750492T3 (da) 2000-12-18

Family

ID=10751813

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913091T DK0750492T3 (da) 1994-03-15 1995-03-13 Inhalationspræparat med indhold af lactose-pellets

Country Status (12)

Country Link
US (2) US6183782B1 (da)
EP (1) EP0750492B1 (da)
AT (1) ATE196989T1 (da)
AU (1) AU2068995A (da)
DE (1) DE69519157T2 (da)
DK (1) DK0750492T3 (da)
ES (1) ES2152394T3 (da)
GB (1) GB9404945D0 (da)
GR (1) GR3034845T3 (da)
PT (1) PT750492E (da)
WO (1) WO1995024889A1 (da)
ZA (1) ZA952049B (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
SE9700135D0 (sv) † 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
EP0876814A1 (en) 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
AU8174601A (en) * 2000-07-31 2002-02-13 Nycomed Danmark As Fentanyl composition for nasal administration
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
PT1292281E (pt) * 2000-10-12 2004-11-30 Boehringer Ingelheim Pharma Novos pos para inalacao contendo tiotropio
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
JP2005530725A (ja) * 2002-04-12 2005-10-13 カンピナ・ネーデルラント・ホールディング・ベスローテン・フェンノートシャップ ドライパウダー吸入製剤において使用する賦形剤
US7947742B2 (en) * 2002-06-28 2011-05-24 Civitas Therapeutics, Inc. Inhalable epinephrine
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20080118442A1 (en) * 2003-09-10 2008-05-22 Map Pharmaceuticals, Inc. Aerosol Formulations for Delivery of Dihydroergotamine to the Systemic Circulations Via Pulmonary Inhalation
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
CA2597557A1 (en) 2005-02-10 2006-08-17 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
EP1944018A1 (en) 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.
EP1964564A1 (en) * 2007-04-19 2008-09-03 LAB International SRL Breakthrough Pain Management
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
TR200909791A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
EP2821061B1 (en) 2013-07-01 2017-12-20 Arven Ilac Sanayi Ve Ticaret A.S. Novel inhalation formulations
US10583085B2 (en) * 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
WO2019201712A1 (en) 2018-04-16 2019-10-24 Ioulia Tseti A pharmaceutical dry powder composition for inhalation comprising a thyroid hormone
JP2022549445A (ja) 2019-09-24 2022-11-25 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 吸入用乾燥粉末製剤のための新規担体粒子

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB398631A (en) 1932-07-28 1933-09-21 Fredk Thomas & Company Ltd Improvements in and connected with lamp-shades
US2897119A (en) * 1957-11-12 1959-07-28 Camp Sea Food Company Inc Van Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
US3341415A (en) * 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787066A (fr) 1971-08-03 1973-02-01 Beecham Group Ltd Compositions pharmaceutiques comprenant de la 2-nitroindane-1,3-dione
GB1410588A (en) 1971-08-10 1975-10-22 Fisons Ltd Composition
GB1478020A (en) 1973-09-14 1977-06-29 Beecham Group Ltd Composition for the treatment of asthma
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB1571629A (en) 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
DE3326089A1 (de) 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
EP0441740B1 (de) 1990-01-29 1993-09-22 Ciba-Geigy Ag Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
EP0721331B1 (en) * 1993-10-01 2001-12-05 AstraZeneca AB Process i
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物

Also Published As

Publication number Publication date
GR3034845T3 (en) 2001-02-28
DE69519157T2 (de) 2001-08-09
PT750492E (pt) 2001-03-30
EP0750492A1 (en) 1997-01-02
US6955824B1 (en) 2005-10-18
EP0750492B1 (en) 2000-10-18
DE69519157D1 (de) 2000-11-23
ZA952049B (en) 1995-12-21
WO1995024889A1 (en) 1995-09-21
ATE196989T1 (de) 2000-11-15
GB9404945D0 (en) 1994-04-27
AU2068995A (en) 1995-10-03
ES2152394T3 (es) 2001-02-01
US6183782B1 (en) 2001-02-06

Similar Documents

Publication Publication Date Title
DK0750492T3 (da) Inhalationspræparat med indhold af lactose-pellets
AU4260496A (en) Propellant mixture for aerosol formulation
MY108748A (en) Medicaments
SE9701956D0 (sv) New composition of matter
GB9426252D0 (en) Pharmaceutical composition
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
MX9605650A (es) Formulaciones de propionato de fluticasona.
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
HUT68498A (en) L-dopa ester compositions and process to prepare them
CA2277365A1 (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
CA2150185A1 (en) Pharmaceutical composition for the treatment of stoma-peripheral inflammation
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
WO1996005836A3 (en) Methods of treating cold symptoms using pentoxifylline
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
EP0904782A4 (en) REMEDY IN THE EVENT OF TRAUMA OF THE SPINE
JPS5585526A (en) Remedy for allergic disease
JPS5732222A (en) Using method of interferon inducer
GR3025410T3 (en) Novel therapeutic use of pycnogenols for the preparation of anti-inflammatory medicaments
IT8222460A1 (it) Esteri 2-metossi-fenilici di acidi 2',4'-difluoro-4-idrossi-(1,1'-bifenil)-3-carbossilici ad attivita' antiinfiammatoria e balsamica, procedimento per la loro preparazione e relative composizioni farmaceutiche